Reckitt Benckiser Group (OTCMKTS:RBGLY) Cut to “Hold” at Sanford C. Bernstein

Sanford C. Bernstein cut shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from a strong-buy rating to a hold rating in a research report sent to investors on Monday,Zacks.com reports.

RBGLY has been the topic of several other reports. Citigroup upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Finally, JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on RBGLY

Reckitt Benckiser Group Stock Performance

Shares of Reckitt Benckiser Group stock opened at $12.39 on Monday. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $15.03. The company’s fifty day simple moving average is $12.24 and its 200-day simple moving average is $11.57. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.